| Entry |
|
|---|
| Name |
Glatiramer acetate (JAN/USAN);
Copaxone (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
(C5H9NO4. C3H7NO2. C6H14N2O2. C9H11NO3)x. (C2H4O2)y
|
|---|
| Remark |
| Therapeutic category: | 3999 |
|
|---|
| Efficacy |
Immunomodulator, T cell receptor antagonist |
|---|
| Disease |
Multiple sclerosis [DS: H01490] |
|---|
| Target |
|
|---|
| Pathway |
| hsa04612 | Antigen processing and presentation |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AX Other immunostimulants
L03AX13 Glatiramer acetate
D04318 Glatiramer acetate (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Central Nervous System Agents
Multiple Sclerosis Agents
Glatiramer
D04318 Glatiramer acetate (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D04318 Glatiramer acetate (JAN/USAN)
Target-based classification of drugs [BR:br08310]
Cell surface molecules and ligands
Cell adhesion molecules: Ig superfamiy
MHC
MHC1
D04318 Glatiramer acetate (JAN/USAN) <JP/US>
MHC2
D04318 Glatiramer acetate (JAN/USAN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D04318
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
